Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Evidence for long-term IVIg treatment of chronic inflammatory demyelinating polyradiculoneuropathy

Nature Clinical Practice Neurology volume 4, pages 352–353 (2008)Cite this article

boxed-textHughes RA et al. (2008) Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 7: 136–144

When choosing a therapy for chronic inflammatory demyelinating polyradiculoneuropathy, IVIg should be considered as an effective and well tolerated—although expensive—option not only for the initial but also for the chronic treatment of the disease

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lunn MPT et al. (1999) Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66: 677–680

    Article  CAS  Google Scholar 

  2. Mehndiratta MM and Hughes RAC (2001) Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No.: CD002062. 10.1002/14651858.CD002062

    Google Scholar 

  3. Mehndiratta MM et al. (2004) Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD003906. 10.1002/14651858.CD003906.pub2

    Google Scholar 

  4. van Schaik IN et al. (2002) Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD001797. 10.1002/14651858.CD001797

    Google Scholar 

  5. Joint Task Force of the EFNS and the PNS (2005) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. J Periph Nerv Sys 10: 220–228

  6. McCrone P et al. (2003) Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Eur J Neurol 10: 687–694

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Neurological Sciences, Milan University, IRCCS Humanitas Clinical Institute, Via Manzoni 56, 20089 Rozzano, Milan, Italy eduardo.nobile@unimi.it

Authors and Affiliations

  1. E Nobile-Orazio is Professor of Neurology at Milan University and Director of the 2nd Neurology Service at IRCCS Humanitas Clinical Institute in Rozzano, Milan, Italy.,

    Eduardo Nobile-Orazio

Authors
  1. Eduardo Nobile-Orazio
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has received speaker's honoraria and grant/research support from Kedrion.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nobile-Orazio, E. Evidence for long-term IVIg treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Nat Rev Neurol 4, 352–353 (2008). https://doi.org/10.1038/ncpneuro0788

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0788

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing